Efficacy and safety of monoclonal antibodies against respiratory syncytial virus disease in premature infants: a systematic review and network meta-analysis - Quiz - MDSpire

Efficacy and safety of monoclonal antibodies against respiratory syncytial virus disease in premature infants: a systematic review and network meta-analysis

  • By

  • Shunli Liu

  • Yan Wang

  • Yang Cao

  • Huiling Song

  • Zhiqing Tian

  • Xue Li

  • Lan Huang

  • July 2, 2026

  • 0 min

Share

Original Source(s)

Efficacy and safety of monoclonal antibodies against respiratory syncytial virus disease in premature infants: a systematic review and network meta-analysis

  • by Shunli Liu, Yan Wang, Yang Cao, Huiling Song, Zhiqing Tian, Xue Li, Lan Huang

  • July 2, 2026

Related Content

FDA Expands Gene Therapy for Younger Patients

Exagamglogene autotemcel is now indicated for patients aged 2 years and older with sickle cell disease and recurrent vaso-occlusive crises or transfusion-dependent beta thalassemia.

Risk and Protective Factors for Suicide Mortality in Youths: A Systematic Review and Meta-Analysis

Case Report: Successful topical simvastatin therapy in a 2-year-old girl with keratin 16-associated palmoplantar epidermal differentiation disorder